Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics

Status Completed

Clinical Trial Summary

This study proposes to establish a CT radiomics-based prediction model for identifying metastasis lymph nodes in esophageal cancer.

Clinical Trial Description

This study proposes to establish an image feature extraction and selection method for identifying lymph node metastasis of esophageal cancer.The study will consider the relationship between the main lesion and the suspected lymph node, extract association characteristics in order to improve the sensitivity and specificity of the CT radiomics-based prediction model for identifying metastasis lymph nodes. The study includes the construction of CT radiomics-based prediction model and the validation of the prediction model. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03237130
Study type	Observational
Source	Beijing Cancer Hospital
Contact
Status	Completed
Phase
Start date	February 15, 2017
Completion date	May 15, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06010862` - Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors	Phase 1
Completed	`NCT00201747` - Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer	Phase 2
Recruiting	`NCT06036563` - Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
Not yet recruiting	`NCT05023928` - Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for Esophagus Cancer	Phase 1
Recruiting	`NCT03941626` - Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies	Phase 1/Phase 2
Recruiting	`NCT04907643` - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	N/A
Recruiting	`NCT02988921` - MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy	N/A
Completed	`NCT02979691` - Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01	Phase 2/Phase 3
Terminated	`NCT02797405` - Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay	N/A
Recruiting	`NCT03347630` - Pre-operative MRI of Esophagus Cancer	N/A
Completed	`NCT00193141` - Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer	Phase 2
Recruiting	`NCT05626309` - Clinical Trial of Qizhu Yuling Prescription in the Prevention and Treatment of Esophagus Cancer	N/A
Completed	`NCT05615129` - Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting
Recruiting	`NCT04821765` - Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer	Phase 2
Terminated	`NCT03108885` - Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
Recruiting	`NCT04046575` - Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer	Phase 1
Recruiting	`NCT06126406` - Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors	Phase 1
Completed	`NCT03467529` - Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot Study
Completed	`NCT02552121` - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors	Phase 1/Phase 2
Completed	`NCT02001623` - Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors	Phase 1/Phase 2